
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tectorigenin protects against unilateral ureteral obstruction by inhibiting Smad3‐mediated ferroptosis and fibrosis
Jianchun Li, Jieke Yang, Bingwen Zhu, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 475-487
Closed Access | Times Cited: 45
Jianchun Li, Jieke Yang, Bingwen Zhu, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 475-487
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
Runzhi Guo, Jiayu Duan, Shaokang Pan, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 46
Runzhi Guo, Jiayu Duan, Shaokang Pan, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 46
Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17
Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling
Bingwen Zhu, Yufang Ni, Yi Gong, et al.
Life Sciences (2022) Vol. 315, pp. 121331-121331
Closed Access | Times Cited: 50
Bingwen Zhu, Yufang Ni, Yi Gong, et al.
Life Sciences (2022) Vol. 315, pp. 121331-121331
Closed Access | Times Cited: 50
Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases
Qi Feng, Yang Yang, Kaidi Ren, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3726-3743
Open Access | Times Cited: 35
Qi Feng, Yang Yang, Kaidi Ren, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3726-3743
Open Access | Times Cited: 35
Role of ferroptosis in chronic kidney disease
Shiyang Li, Qiuxia Han, Chang Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Shiyang Li, Qiuxia Han, Chang Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia–reperfusion injury
Chen-Hua Zhang, Yujie Yan, Qi Luo
Life Sciences (2024) Vol. 340, pp. 122439-122439
Open Access | Times Cited: 13
Chen-Hua Zhang, Yujie Yan, Qi Luo
Life Sciences (2024) Vol. 340, pp. 122439-122439
Open Access | Times Cited: 13
Natural product-derived ferroptosis mediators
Yili Chen, Lin-An Xiong, Lie‐Feng Ma, et al.
Phytochemistry (2024) Vol. 219, pp. 114002-114002
Closed Access | Times Cited: 13
Yili Chen, Lin-An Xiong, Lie‐Feng Ma, et al.
Phytochemistry (2024) Vol. 219, pp. 114002-114002
Closed Access | Times Cited: 13
A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives
Zhongyu Han, Yuanke Luo, Haoran Chen, et al.
Kidney Diseases (2024) Vol. 10, Iss. 3, pp. 224-236
Open Access | Times Cited: 11
Zhongyu Han, Yuanke Luo, Haoran Chen, et al.
Kidney Diseases (2024) Vol. 10, Iss. 3, pp. 224-236
Open Access | Times Cited: 11
Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis
Jian Jia, Ruizhi Tan, Linghui Xu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112303-112303
Closed Access | Times Cited: 9
Jian Jia, Ruizhi Tan, Linghui Xu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112303-112303
Closed Access | Times Cited: 9
Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
Zhiyong Long, Yanfang Luo, Min Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Zhiyong Long, Yanfang Luo, Min Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Natural Flavonoids and Ferroptosis: Potential Therapeutic Opportunities for Human Diseases
Zheng Zhou, Jiye Li, Xiaochuan Zhang
Journal of Agricultural and Food Chemistry (2023)
Closed Access | Times Cited: 18
Zheng Zhou, Jiye Li, Xiaochuan Zhang
Journal of Agricultural and Food Chemistry (2023)
Closed Access | Times Cited: 18
Tectorigenin: A Review of Its Sources, Pharmacology, Toxicity, and Pharmacokinetics
Juan Rong, Fei Fu, Chenxia Han, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5904-5904
Open Access | Times Cited: 18
Juan Rong, Fei Fu, Chenxia Han, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5904-5904
Open Access | Times Cited: 18
HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis
Xin Li, Tian‐Kui Ma, Pu Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 8
Xin Li, Tian‐Kui Ma, Pu Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 8
Kaempferitrin attenuates unilateral ureteral obstruction‐induced renal inflammation and fibrosis in mice by inhibiting NOX4 ‐mediated tubular ferroptosis
Jianchun Li, Jieke Yang, Qianwen Xian, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2656-2668
Closed Access | Times Cited: 7
Jianchun Li, Jieke Yang, Qianwen Xian, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2656-2668
Closed Access | Times Cited: 7
TGF‑β/Smad signaling in chronic kidney disease: Exploring post‑translational regulatory perspectives (Review)
Jianchun Li, Yuanxia Zou, Jiraporn Kantapan, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 7
Jianchun Li, Yuanxia Zou, Jiraporn Kantapan, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 7
Beyond Mortality: Exploring the Influence of Plant Phenolics on Modulating Ferroptosis—A Systematic Review
Nemanja Živanović, Marija Lesjak, Nataša Simin, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 334-334
Open Access | Times Cited: 6
Nemanja Živanović, Marija Lesjak, Nataša Simin, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 334-334
Open Access | Times Cited: 6
Ferroptosis in organ fibrosis: From mechanisms to therapeutic medicines
Weijing Lai, Bo Wang, Rongshuang Huang, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 22-34
Open Access | Times Cited: 6
Weijing Lai, Bo Wang, Rongshuang Huang, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 22-34
Open Access | Times Cited: 6
Therapeutic Implications of Ferroptosis in Renal Fibrosis
Yao Zhang, Yanhua Mou, Jianjian Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 28
Yao Zhang, Yanhua Mou, Jianjian Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 28
Role of Ferroptosis in Fibrotic Diseases
Jian Zhou, Yuan Tan, Rurong Wang, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 3689-3708
Open Access | Times Cited: 23
Jian Zhou, Yuan Tan, Rurong Wang, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 3689-3708
Open Access | Times Cited: 23
Tectorigenin relieved sepsis-induced myocardial ferroptosis by inhibiting the expression of Smad3
Xiaowei Fang, Wei Fu, Bing Zou, et al.
Toxicology Research (2023) Vol. 12, Iss. 3, pp. 520-526
Open Access | Times Cited: 11
Xiaowei Fang, Wei Fu, Bing Zou, et al.
Toxicology Research (2023) Vol. 12, Iss. 3, pp. 520-526
Open Access | Times Cited: 11
Natural flavonoids act as potent ferroptosis inhibitors and their potentials in the treatment of ferroptosis-associated diseases
Lu Liu, Lun Wang, Ying Xiao, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100377-100377
Open Access | Times Cited: 4
Lu Liu, Lun Wang, Ying Xiao, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100377-100377
Open Access | Times Cited: 4
Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases
Tiancheng Xie, Li Yao, Xiaogang Li
Antioxidants (2024) Vol. 13, Iss. 6, pp. 659-659
Open Access | Times Cited: 4
Tiancheng Xie, Li Yao, Xiaogang Li
Antioxidants (2024) Vol. 13, Iss. 6, pp. 659-659
Open Access | Times Cited: 4
TEC-mediated tRF-31R9J regulates histone lactylation and acetylation by HDAC1 to suppress hepatocyte ferroptosis and improve non-alcoholic steatohepatitis
Juanjuan Zhu, Xian Wu, Mao Mu, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Juanjuan Zhu, Xian Wu, Mao Mu, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches
Zhi-Hong Ning, Xiuheng Wang, Yue Zhao, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114341-114341
Closed Access
Zhi-Hong Ning, Xiuheng Wang, Yue Zhao, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114341-114341
Closed Access
Tectorigenin mitigates homocysteine-induced inflammation and ferroptosis in BV-2 microglial cells through promoting the SIRT1/SLC7A11 pathway
Yin Ye, Bo Wang, Yan Yang, et al.
Brain Research Bulletin (2025), pp. 111272-111272
Open Access
Yin Ye, Bo Wang, Yan Yang, et al.
Brain Research Bulletin (2025), pp. 111272-111272
Open Access